Evidence map›Paper›PMID 39864404›Full record

ArticleJournal of neuropathology and experimental neurology2025

Cytoplasmic expression of trans-active response DNA-binding protein-43 in aged mice display hippocampal sclerosis-like degeneration and neuronal loss with reduced lifespan.

Ashley J Anderson, Matthew B Dopler, Sanaz Arezoumandan, Damian Osei-Kankam, Stephani A Davis, Kaouther Ajroud, Jaclyn Lilek, Eva Bambakadis, Rachel Shapiro, Margaret E Flanagan and 2 more

Abstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ashley J AndersonDepartment of Biological Sciences, Delaware State University, Dover, DE, United States.ORCID 0000-0002-4744-7614
Matthew B DoplerDepartment of Biological Sciences, Delaware State University, Dover, DE, United States.ORCID 0000-0002-9708-8090
Sanaz ArezoumandanDepartment of Biological Sciences, Delaware State University, Dover, DE, United States.ORCID 0000-0001-6569-9009
Damian Osei-KankamDepartment of Biological Sciences, Delaware State University, Dover, DE, United States.
Stephani A DavisDepartment of Biological Sciences, Delaware State University, Dover, DE, United States.
Kaouther AjroudBigg's Institute for Alzheimer's Disease and Dementia, University of Texas Health San Antonio, San Antonio, TX, United States.ORCID 0000-0002-2891-1186
Jaclyn LilekBigg's Institute for Alzheimer's Disease and Dementia, University of Texas Health San Antonio, San Antonio, TX, United States.ORCID 0000-0002-7085-8331
Eva BambakadisBigg's Institute for Alzheimer's Disease and Dementia, University of Texas Health San Antonio, San Antonio, TX, United States.
Rachel ShapiroBigg's Institute for Alzheimer's Disease and Dementia, University of Texas Health San Antonio, San Antonio, TX, United States.ORCID 0000-0002-6865-3097
Margaret E FlanaganBigg's Institute for Alzheimer's Disease and Dementia, University of Texas Health San Antonio, San Antonio, TX, United States.ORCID 0000-0002-8360-2618
Nigel J CairnsLiving Systems Institute, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.ORCID 0000-0001-9858-3344
Michael A GitchoDepartment of Biological Sciences, Delaware State University, Dover, DE, United States.ORCID 0000-0002-9223-5426

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI Shawn W Polson · 2012 to 2026
$67.2M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Mohamad Habes · 2021 to 2026
$24.0M
Updated confocal microscope in the Imaging Core facility to support biomedical researchP20GM103653 · NIGMS · DELAWARE STATE UNIVERSITY · PI HARRINGTON, MELISSA A · 2012 to 2022
$22.7M
Federated digital pathology platform for AD/ADRD research and diagnosticsU24NS133945 · NINDS · UNIVERSITY OF KENTUCKY · PI BUMGARDNER, CODY, FLANAGAN, MARGARET E · 2023 to 2025
$4.9M
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approachesR01AG082118 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI BONAKDARPOUR, BORNA, CHENG, FEIXIONG · 2023 to 2025
$2.4M
Exploring the origins of myelin abnormalities in normal ageing and in vascular dementiaRF1AG072080 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FLANAGAN, MARGARET E, POPKO, BRIAN J · 2021 to 2021
$2.2M
Exploring the origins of myelin abnormalities in normal ageing and in vascular dementiaR01AG072080 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FLANAGAN, MARGARET E, POPKO, BRIAN J · 2024 to 2025
$1.4M
nvestigating the role of neuroinflammation in Limbic-predominant age related TDP43 encephalopathyK08AG065463 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FLANAGAN, MARGARET E · 2020 to 2024
$816k
Centers of Biomedical Research Excellence 5P20GM103653Delaware Community FoundationDelaware INBRENIA NIH HHS K08 AG065463NIA NIH HHS K08AG065463NIA NIH HHS P30 AG066546NIA NIH HHS R01 AG072080NIA NIH HHS R01 AG082118NIA NIH HHS RF1 AG072080NIA NIH HHS RF1AG072080NIGMS NIH HHS P20 GM103446NIGMS NIH HHS P20 GM103653NIH HHSNINDS NIH HHS U24 NS133945NINDS NIH HHS U24NS133945Paul H. Boerger Fund of the Delaware Community Foundation
6 · The paper itself

Abstract

Trans-active response DNA-binding protein-43 (TDP-43) is the major pathological protein in motor neuron disease and TDP-43 pathology has been described in the brains of up to 50% of patients with Alzheimer disease (AD). Hippocampal sclerosis of aging (HS-A), an age-related neuropathology characterized by severe neuronal loss and gliosis in CA1 and/or subiculum, is found in ∼80% of cases that are positive for phosphorylated TDP-43. HS-A is seen as a co-pathology in cases with AD, limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes (LATE-NC), and frontotemporal degeneration. To understand the pathogenetic relationships between HS-A and LATE-NC, mice that selectively express human TDP-43 and TDP-43 with a defective nuclear localization signal (ΔNLS) in the hippocampus, alone or in an APP/PSEN1 background, were evaluated using histology, HALO software's object recognition algorithms, and protein expression assays. Twenty-four-month-old mice expressing cytosolic TDP-43 displayed marked neuronal loss and atrophy in the hippocampus, decreased β-amyloid plaque deposition and modulation of microglia and intermediate filament activation. TDP-43ΔNLS-expressing mice survived to only ∼24 months of age whether or not they had an APP/PSEN1 background. This HS-A-like model may provide insights into the pathogenesis of neurodegeneration seen in HS-A and in other TDP-43 proteinopathies.

Indexed as

AgingCytoplasmDNA-Binding ProteinsHippocampusNerve DegenerationNeuronsAmyloid beta-Protein PrecursorAnimalsFemaleHippocampal SclerosisHumansMaleMiceMice, Inbred C57BLMice, TransgenicPresenilin-1Amyloid beta-Protein PrecursorDNA-Binding ProteinsPresenilin-1TARDBP protein, humanTardbp protein, mouseAlzheimer diseaseamyloidAPP/PS1 mousehippocampal sclerosis of aginglimbic-predominant age-related TDP-43 encephalopathyneurodegenerationTDP-43

Identifiers

PMID39864404
PMCPMC11923740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.